Sex is a potent modifier of the cardiovascular system

Journal of Clinical Investigation

Volumn 112, Issue 3, 2003, Pages 302-307

  Leinwand, Leslie A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; ESTRADIOL; ESTROGEN; GENISTEIN; PHYTOESTROGEN; SEX HORMONE; TESTOSTERONE; ISOFLAVONE DERIVATIVE; PLANT MEDICINAL PRODUCT;

CARDIOVASCULAR SYSTEM; DISEASE ASSOCIATION; HEART DISEASE; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SEX DIFFERENCE; ANIMAL; CARDIOVASCULAR FUNCTION; COMPARATIVE STUDY; DIET; FEMALE; GROWTH, DEVELOPMENT AND AGING; HEART; HISTOLOGY; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEXUAL DEVELOPMENT;

ANIMALS; CARDIOVASCULAR PHYSIOLOGY; DIET; ESTROGENS, NON-STEROIDAL; FEMALE; GONADAL STEROID HORMONES; HEART; HEART DISEASES; HUMANS; ISOFLAVONES; MALE; PHYTOESTROGENS; PLANT PREPARATIONS; SEX CHARACTERISTICS;

EID: 0042889028     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200319429     Document Type: Review

References (66)

1. Committee on Understanding the Biology of Sex and Gender Differences. 2001. Exploring the biological contributions to human health: does sex matter? The National Academies Press. Washington, D.C., USA. 288 pp.
2. Rossouw, J.E., et al. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized control trial. JAMA. 288:321-333.
3. 1B-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J. Clin. Invest. 111:1783-1791. doi:10.1172/ JCI200316100.
4. Malcolm, D.D., Burns, T.L., Mahoney, L.T., and Lauer, R.M. 1993. Factors affecting left ventricular mass in childhood: the Muscatine Study. Pediatrics. 92:703-709.
5. de Simone, G., et al. 1995. Gender differences in left ventricular growth. Hypertension. 26:979-983.
6. Grandi, A.M., et al. 1992. Influence of age and sex on left ventricular anatomy and function in normals. Cardiology. 81:8-13.
7. Aronow, W.S., Ahn, C., and Kronzon, I. 1999. Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites. Am. J. Cardiol. 84:611-612.
8. De Maria, R., et al. 1993. Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men. The Italian Multicenter Cardiomyopathy Study Group (SPIC). Am. J. Cardiol. 72:580-585.
9. Adams, K.F., Jr., et al. 1999. Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation. 99:1816-1821.
10. Douglas, P.S., et al. 1995. Gender differences in left ventricle geometry and function in patients undergoing balloon dilatation of the aortic valve for isolated aortic stenosis. NHLBI Balloon Valvuloplasty Registry. Br. Heart J. 73:548-554.
11. Aurigemma, G.P., Silver, K.H., McLaughlin, M., Mauser, J., and Gaasch, W.H. 1994. Impact of chamber geometry and gender on left ventricular systolic function in patients > 60 years of age with aortic stenosis. Am. J. Cardiol. 74:794-798.
12. Aurigemma, G.P., and Gaasch, W.H. 1995. Gender differences in older patients with pressure-overload hypertrophy of the left ventricle. Cardiology. 86:310-317.
13. Kimmelstiel, C.D., and Konstam, M.A. 1995. Heart failure in women. Cardiology. 86:304-309.
14. Legget, M.E., et al. 1996. Gender differences in left ventricular function at rest and with exercise in asymptomatic aortic stenosis. Am. Heart J. 131:94-100.
15. Grady, D., et al. 2000. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/Progestin Replacement Study. Ann. Intern. Med. 132:689-696.
16. Mohan, S.B., Parker, M., Wehbi, M., and Douglass, P. 2002. Idiopathic dilated cardiomyopathy: a common but mystifying cause of heart failure. Cleve. Clin. J. Med. 69:481-487.
17. Fernandez-Sola, J., and Nicolas-Arfelis, J.M. 2002. Gender differences in alcoholic cardiomyopathy. J. Gend. Specif. Med. 5:41-47.
18. National Center for Health Statistics. 1997. Statistical abstract of the United States. 117th edition. US Bureau of the Census. Washington, DC, USA. 83 pp. http://www.census.gov/prod/www/statistical-abstract-us.html.
19. Capasso, J.M., Remily, R.M., Smith, R.H., and Sonnenblick, E.H. 1983. Sex differences in myocardial contractility in the rat. Basic Res. Cardiol. 78:156-171.
20. Schaible, T.F., and Scheuer, J. 1984. Comparison of heart function in male and female rats. Basic Res. Cardiol. 79:402-412.
21. Leblanc, N., Chartier, D., Gosselin, H., and Rouleau, J.L. 1998. Age and gender differences in excitation-contraction coupling of the rat ventricle. J. Physiol. 511:533-548.
22. Freeman, K., et al. 2001. Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J. Clin. Invest. 107:967-974.
23. Pelzer, T., Shamim, A., Wolfges, S., Schumann, M., and Neyses, L. 1997. Modulation of cardiac hypertrophy by estrogens. Adv. Exp. Med. Biol. 432:83-89.
24. Grohe, C., et al. 1994. Functional estrogen receptors in myocardial and myogenic cells. Circulation. 90:I538. (Abstr.)
25. Grohe, C., et al. 1996. Modulation of hypertensive heart disease by estrogen. Steroids. 61:201-204.
26. Klein-Hitpass, L., Schorpp, M., Wagner, U., and Ryffel, G.U. 1986. An estrogen-responsive element derived from the 5′flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell. 46:1053-1061.
27. Grohe, C., et al. 1997. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett. 416:107-112.
28. Marsh, J.D., et al. 1998. Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation. 98:256-261.
29. Koenig, H., Goldstone, A., and Lu, C.Y. 1982. Testosterone-mediated sexual dimorphism of the rodent heart. Ventricular lysosomes, mitochondria, and cell growth are modulated by androgens. Circ. Res. 50:782-787.
30. Morano, I., et al. 1990. Regulation of myosin heavy chain expression in the hearts of hypertensive rats by testosterone. Circ. Res. 66: 1585-1590.
31. Malhotra, A., Buttrick, P., and Scheuer, J. 1990. Effects of sex hormones on development of physiological and pathological cardiac hypertrophy in male and female rats. Am. J. Physiol. 259:H866-H871.
32. Morris, G.S., et al. 1998. Ovariectomy fails to modify the cardiac myosin isoenzyme profile of adult rats. Horm. Metab. Res. 30:84-87.
33. Scheuer, J., Malhotra, A., Schaible, T.F., and Capasso, J. 1987. Effects of gonadectomy and hormonal replacement on rat hearts. Circ. Res. 61:12-19.
34. Schaible, T.F., Malhotra, A., Ciambrone, G., and Scheuer, J. 1984. The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circ. Res. 54:38-49.
35. Sharkey, L.C., et al. 1998. Effect of ovariectomy in heart failure-prone SHHF/Mcc-facp rats. Am. J. Physiol. 275:RI968-RI976.
36. Thigpen, J.E., et al. 1999. Phytoestrogen content of purified, open- and closed-formula laboratory animal diets. Lab Anim. Sci 49:530-536.
37. Degen, G.H., Janning, P., Diel, P., and Bolt, H.M. 2002. Estrogenic isoflavones in rodent diets. Toxicol. Lett. 128:145-157.
38. Boettger-Tong, H., et al. 1998. A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens. Environ. Health Perspect. 106:369-373.
39. Day, J.K., et al. 2002. Genistein alters methylation patterns in mice. J. Nutr. 132:2419S-2423S.
40. Barkhem, T., et al. 1998. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol. Pharmacol. 54:105-112.
41. Kuiper, G.G., et al. 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 139:4252-4263.
42. Chinni, S.R., Alhasan, S.A., Multani, A.S., Pathak, S., and Sarkar, F.H. 2003. Pleotropic effects of genistein on MCF-7 breast cancer cells. Int. J. Mol. Med. 12:29-34.
43. Matsui, T., et al. 2002. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J. Biol. Chem. 277:22896-22901.
44. Shioi, T., et al. 2002. Akt/protein kinase B promotes organ growth in transgenic mice. Mol. Cell Biol. 22:2799-2809.
45. Martin, D.S., Breitkopf, N.P., Eyster, K.M., and Williams, J.L. 2001. Dietary soy exerts an antihypertensive effect in spontaneously hypertensive female rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281:R553-R560.
46. Nikawa, T., et al. 2002. Effects of a soy protein diet on exercise-induced muscle protein catabolism in rats. Nutrition. 18:490-495.
47. Zhai, P., et al. 2001. Effects of dietary phytoestrogen on global myocardial ischemia-reperfusion injury in isolated female rat hearts. Am. J. Physiol. Heart Circ. Physiol. 281:H1223-H1232.
48. Rivas, M., et al. 2002. Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J. Nutr. 132:1900-1902.
49. Washburn, S., Burke, G.L., Morgan, T., and Anthony, M. 1999. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause. 6:7-13.
50. Food and Drug Administration Talk Paper. October 20, 1999. http://www.fda.gov/bbs/topics/answers/ans00980.html.
51. Weinberg, E.O., et al. 1999. Gender differences in molecular remodeling in pressure overload hypertrophy. J. Am. Coll. Cardiol. 34:264-273.
52. Tamura, T., Said, S., and Gerdes, A.M. 1999. Gender-related differences in myocyte remodeling in progression to heart failure. Hypertension. 33:676-680.
53. Wallen, W.J., Cserti, C., Belanger, M.P., and Wittnich, C. 2000. Gender-differences in myocardial adaptation to afterload in normatensive and hypertensive rats. Hypertension. 36:774-779.
54. Freshour, J.R., Chase, S.E., and Vikstrom, K.L. 2002. Gender differences in cardiac ACE expression are normalized in androgen-deprived male mice. Am. J. Physiol. Heart Circ. Physiol. 283:H1997-H2003.
55. Miyata, S., Minobe, W., Bristow, M.R., and Leinwand, L.A. 2000. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ. Res. 86:386-390.
56. Trepanier-Boulay, V., St-Michel, C., Tremblay, A., and Fiset, C. 2001. Gender-based differences in cardiac repolarization in mouse ventricle. Circ. Res. 89:437-444.
57. Wu, Y., and Anderson, M.E. 2002. Reduced repolarization reserve in ventricular myocytes from female mice. Cardiovasc. Res. 53:763-769.
58. Freeman, K., et al. 2001. Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. Am. J. Physiol. Heart Circ. Physiol. 280:151-159.
59. Tardiff, J.C., et al. 1999. Cardiac troponin T mutations result in allele. specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J. Clin. Invest. 104:469-481.
60. Haghighi, K., et al. 2001. Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure. J. Biol Cbem. 276:24145-24152.
61. Dash, R., et al. 2003. Differential regulation of p38 mitogen-activated protein kinase mediates gender-dependent catecholamine-induced hypertrophy. Cardiovasc. Res. 57:704-714.
62. Duan, J., et al. 2003. Influence of gender on ethanol-induced ventricular myocyte contractile depression in transgenic mice with cardiac overexpression of alcohol dehydrogenase. Comp. Biochem. Physiol. Mol. Integr. Physiol. 134:607-614.
63. Janczewski, A.M., et al. 2003. Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-α. Am. J. Physiol. Heart Circ. Physiol. 284:H960-H969.
64. Nohammer, C., et al. 2003. Myocardial dysfunction and male mortality in peroxisome proliferator-activated receptor alpha knockout mice overexpressing lipoprotein lipase in muscle. Lab Invest. 83:259-269.
65. Du, X.J., et al. 2003. Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype. Cardiovasc. Res. 57:395-404.
66. Cross, H.R., Murphy, E., Koch, W. J., and Steenbergen, C. 2002. Male and female mice overexpressing the beta(2)-adrenergic receptor exhibit differences in ischemia/reperfusion injury: role of nitric oxide. Cardiovasc. Res. 53:662-671.